Brain Marker Shows Promise For Predicting Future Alzheimer's Disease
Researchers have used imaging technology to identify a new marker that may help identify those at greatest risk for cognitive decline and the development of Alzheimer's disease.
|
Scientists Use Shared Genome Data To Confirm Gene Linked To Alzheimer's
Until recently, only one of the approximately 30,000 genes in the human genome has been linked to risk of late-onset Alzheimer's disease (AD).
|
Dementia prevalent in 1 or 7 Americans
About 2.4 million of those with dementia, or 9.7 percent of the population age 71 and older, were found to have Alzheimer's disease, the most common cause of dementia, according to the study.
|
Alzheimer's Disease Treatment Possible With Blood Pressure Drug
Alzheimer's disease treatment with certain antihypertensive agents might be of benefit to individuals with, or at high risk of developing, Alzheimer's disease.
|
Holiday Gifts Help Fight Alzheimer's Disease
This year, choose a gift that will brighten someone's holiday and contribute to the fight against Alzheimer's disease, the seventh leading cause of death in the United States.
|
Texas County Distributes Book On Alzheimer's Focused On Blacks
'The Book of Alzheimer's for African-American Churches' details information and facts about the disease from Texas prospective.
|
Trial Of MEM 1003 In Alzheimer's Disease Shows Positive Results
Memory Pharmaceuticals announced top-line data from the multi-center, randomized, double-blind, placebo-controlled Phase 2a study of MEM 1003, a neuronal L-type calcium channel modulator, in Alzheimer's disease.
|
Scientists On Verge of Alzheimer's Disease Blood Test
An international team of scientists are developing the first blood test for Alzheimer's disease which experts hope will help doctors identify patients with the memory-robbing disease in its earliest stages.
|
The Risk Of Alzheimer's Disease Can Be Predicted By Blood Test
The blood test for the prediction of Alzheimer's disease identifies changes in a handful of proteins in blood plasma that cells use to convey messages to one another.
|
Cautious Optimism For New Alzheimer's Medications
Alzheimer's disease takes a long time to develop, which suggests that it may be possible to design drugs that work early in the disease process, to delay the start of symptoms.
|
Low Level Of Conscientiousness - Risk Factor For Alzheimer's Disease
Individuals who are more conscientious - in other words, those with a tendency to be self - disciplined, scrupulous and purposeful - appear less likely to develop Alzheimer's disease.
|
Alzheimer's Caregivers Get Sage Advice
Russell Public Communications announces the release of a new book that aims to ease the challenges faced by caregivers of Alzheimer's patients.
|
Mediterranean Diet May Help Alzheimer's Patients Live Longer
A Mediterranean diet may help people with Alzheimer's disease live longer than patients who eat a more traditional Western diet.
|
Cognitive Activities Protect Against Alzheimer's
New research now shows for the first time that, of all lifelong activities, only a high level of mental or cognitive activity protects against the devastating memory loss of Alzheimer's disease.
|
Diagnose Alzheimer's Before Dementia Onset
New advances make it possible to recognize changes of Alzheimer's disease earlier than ever.
|
Brain Network May Help Prevent or Slow Alzheimer's Disease
This finding may provide a hint about how higher levels of cognitive reserve - which is believed to build by regularly engaging in mentally-stimulating activities such as taking classes, gardening and volunteering, provides protection against Alzheimer's disease or dementia by "exercising" the brain.
|
Researcher Goes 'Through the Nose' to Delay Onset of Alzheimer's Disease
A new drug candidate dissolves plaques associated with Alzheimer's disease and other neurological diseases.
|
Benefits Of Communicating With Those Who Have Alzheimer's Disease
There is a Bridge, reveals different ways of communicating with those who have Alzheimer's disease.
|
Research Links Protein, Stem Cells and Potential Alzheimer's Treatment
A team of scientists led by professor Kiminobu Sugaya at the University of Central Florida may have found a new way to treat Alzheimer's disease.
|
New Alzheimer's Disease Treatment May Reverse Signs
Scientists in Scotland are one step further to finding a treatment for Alzheimer's disease, thanks to the development of a compound which reverses signs of the disease.
|
Drug Improves Symptoms Of Severe Alzheimer's Disease
A drug initially used to treat mild to moderate Alzheimer's disease improved the memory and global function of people with severe Alzheimer's disease.
|
Can Fish Oil Slow Alzheimer's disease?
Millions of Americans swallow fish oil, hoping that omega-3 acids inside will protect their brains against memory loss and dementia. New study tests the effectiveness of fish oil on Alzheimer's disease.
|
Groups Seek To Address Cultural Barriers To Alzheimer's Disease Care
Alzheimer's Association has begun a campaign to address cultural barriers to care for dementia patients in minority communities.
|
Frequent Brain Stimulation In Old Age Reduces Risk Of Alzheimer's Disease
How often older adults read a newspaper, play chess, or engage in other mentally stimulating activities is related to the risk of developing Alzheimer's disease.
|
Exelon Skin Patch For Treatment of Alzheimer's Disease Gets Approval
Exelon Patch, the first and only skin patch for the treatment of Alzheimer's disease, receives first worldwide approval in US.
|
Frequent Brain Stimulation In Old Age Reduces Risk Of Alzheimer's Disease
How often old people read a newspaper, play chess, or engage in other mentally stimulating activities is related to risk of developing Alzheimer's disease.
|
Alzheimer's Drug Treatments Issue In Britain's High Court
Pharmaceutical companies and a group of patients with Alzheimer's disease went to Britain's High Court on Monday in order to force National health service to give all patients access to three drug treatments for the Alzheimer's disease which are Aricept, Reminyl and Exelon- three inhibitors.
|
Researchers Examine Plaque Formation Linked To Alzheimer's Disease
Researchers are unraveling the mystery of how unique plaque accumulates in the brains of Alzheimer's disease patients.
|
Mix Of Disease Processes At Work In Brains Of Most People With Dementia
Few older people die with brains untouched by a pathological process, however, an individual's likelihood of having clinical signs of dementia increases with the number of different disease processes present in the brain.
|
First Phase III Trial Of An Anti-Amyloid Drug In Alzheimer's Disease
Data from clinical trials of four possible Alzheimer's therapies raise hope for an emerging new era in treatment of the disease.
|
Early Results From Alzheimer's Neuroimaging Biomarker Project Show Promise For Faster Study Of Therapies
Alzheimer's disease researchers may be able to reduce the time and expense associated with clinical trials.
|
Dimebon Maintains Benefit on All Endpoints in Alzheimer's Disease
Alzheimer's Disease Drug Medivation's Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy.
|
Estimate Of Worldwide Prevalence Of Alzheimer's Disease Is 26.6 Million
The latest worldwide estimate of Alzheimer's disease prevalence shows that 26.6 million people were living with the disease in 2006.
|
Boomers Caring For Parents And Spouses Afflicted With Alzheimer's
Alzheimer's disease currently afflicts more than 5 million Americans and 70 percent of them live at home, where they are cared for by millions of daughters, sons and spouses.
|
Home Visits Improve Willingness To Participate In Alzheimer's Clinical Trials
Alzheimer's clinical trials that include home visits could result in shorter recruitment periods and increased patient retention rates, and may save considerable time and expense.
|
MRI Image Technique Predicts Early Onset Of Alzheimer's Disease In Patients With Mild Memory Problems
Using new MRI techniques to analyze tissue composition and structure in the brain, researchers detected mild cognitive disorder, a condition in which patients suffer mild memory problems and is often an early symptom of Alzheimer's disease.
|
Early Alzheimer's Detection by Gene 'Signature' In Blood Possible
With anticipation running high of breakthroughs in Alzheimer's disease therapies, reports of the latest results from studies on early detection of Alzheimer's took on added urgency.
|
Explaining Link Between Strokes And Alzheimer's
University of Leeds scientists have shown how stroke victims could be more vulnerable to Alzheimer's disease - years or even decades after making a full recovery.
|
Nursing Home Placement Linked To Accelerated Cognitive Decline in Alzheimer's Disease
Study by Rush Alzheimer's Disease Center finds adult day care may help the transition.
|
Exonhit Aims To Ask For Market Clearance For Blood Diagnostic Test For Alzheimer's Disease
ExonHit Therapeutics will ask for certification in Europe, and for market clearance in the USA, as early as 2009 for a multi-gene expression test assisted by an algorithm to produce a score that determines whether the patient is deemed with Alzheimer's disease.
|
